Mehta Rutika - H Lee Moffitt Canc Ctr & Res Inst

基本信息

浏览量：63

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 178 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Detecting Early Recurrence with Circulating Tumor DNA in Stage I-III Biliary Tract Cancer after Curative Resection

James Yu,Aiwu Ruth He, Mahmoud Ouf,Rutika Mehta,Daniel A. Anaya,Jason Denbo, Catherine Bridges,Antony Tin,Vasily N. Aushev,Charuta C. Palsuledesai,Shruti Sharma,Adham Jurdi,Minetta C. Liu,Richard D. Kim

JCO PRECISION ONCOLOGY (2025)

引用0浏览0WOS引用

Biomarker-Driven Approach to the Treatment of Metastatic Gastric or Gastroesophageal Adenocarcinoma

James Yu,Rutika Mehta

Journal of the National Comprehensive Cancer Network JNCCNno. 5 (2025)

引用0浏览0WOS引用

NRG-GI007: Secondary Endpoints of Safety Assessment and Clinical Complete Response (ccr) of Chemoradiation with Endoscopically Injected Oncolytic Virus OBP-301 in Medically Inoperable Esophageal Cancer

Geoffrey Yuyat Ku,Jennifer Moughan,Terence Marques Williams,Prasad S. Adusumilli,Makoto Nishimura,Adam Yock,Rutika Mehta,Jessica M. Frakes,Abraham Jing-Ching Wu,Eric David Miller,Samuel J. Klempner,Kathryn A. Winter,Theodore S. Hong

Journal of Clinical Oncologyno. 4_suppl (2025): 435-435

引用0浏览0引用

Adverse Events (aes) –derived Biomarker in Predicting Clinical Outcomes in Patients with Colorectal Cancer (CRC) Treated with Immunotherapy (IC)

Dung-Tsa Chen,Rutika Mehta,Richard D. Kim,Jennifer B Permuth,Timothy I Shaw,Dae Won Kim

Journal of Clinical Oncologyno. 4_suppl (2025): 132-132

引用0浏览0引用

A Phase II Study of Neratinib (nera) in Combination with Chemotherapy/trastuzumab/pembrolizumab (C/T/P) in HER2 Overexpressing Gastroesophageal Cancers (Gecs)

Dae Won Kim, Lauren Ponto, Allan Andresson Lima Pereira,Richard D. Kim, Chandler Kracht,Gregory Lauwers,Jose Mario Pimiento,Tiago Biachi de Castria,Jonathan R. Strosberg,Mintallah Haider,Iman Imanirad, Trenton A Avriett,James Costello,Sarah E. Hoffe,Dung-Tsa Chen,Sarbajit Mukherjee,Rutika Mehta

Journal of Clinical Oncologyno. 4_suppl (2025)

引用0浏览0引用

Zanidatamab Plus Chemotherapy As First-Line Treatment for Patients with HER2-positive Advanced Gastro-Oesophageal Adenocarcinoma: Primary Results of a Multicentre, Single-Arm, Phase 2 Study

Elena Elimova, Jaffer Ajani, Howard Burris,Crystal S Denlinger,Syma Iqbal, Yoon-Koo Kang,Jwa Hoon Kim,Keun-Wook Lee, Bruce Lin,Rutika Mehta, Do-Youn Oh,Sun Young Rha,Young Mi Seol, Lin Yang, Mark A Ozog,Phillip M Garfin, Geoffrey Ku

The Lancet Oncology (2025)

引用0浏览0WOS引用

Supplementary Table S11 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

引用0浏览0引用

Supplementary Figure S2 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

引用0浏览0引用

Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers

Adrienne B. Shannon,Rutika Mehta,Shaffer R. Mok,Gregory Y. Lauwers,Jobelle J. A. R. Baldonado,Jacques Fontaine,Jose M. Pimiento,Andrew J. Sinnamon

ANNALS OF SURGICAL ONCOLOGY（2024）

引用0浏览0WOS引用

Supplementary Table S9 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn